Cardiopulmonary toxicity of thoracic radiotherapy.
Recruiting
- Conditions
- Cardiopulmonary toxicitypulmonary hypoertension100822061003745410047066
- Registration Number
- NL-OMON48574
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 240
Inclusion Criteria
• Patients with oesophageal cancer in the mid or distal oesophagus and patients
with NSCLC stage IIA-III or NSCLC stage IV with limited brain metastases
(treatable with surgery or stereotactic radiosurgery) or SCLC limited disease
(stage I-IIIB)
• Scheduled for external-beam radiotherapy with curative intention.
• WHO 0-2.
• Age >= 18 years
• Written informed consent.
Exclusion Criteria
• Heart failure in the last 2 months
• Pulmonary embolism in the last 2 months
• COPD gold IV
• BMI >35
• History of thoracic radiotherapy
• Noncompliance with any of the inclusion criteria
- For MRI part: Contra indications for MRIFor MRI part:
• contra-indications for MRI
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method